Clinical trial
Reliable Methods to Assess Kidney Function for Drug Dosage Adjustments in Critically Ill Patients - Comparison of Timed Clearance of Creatinine and Creatinine Based Estimated GFR
NCT03045692 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reliable Methods to Assess Kidney Function for Drug Dosage Adjustments in Critically Ill Patients - Comparison of Timed Clearance of Creatinine and Creatinine Based Estimated GFR
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 13, 2017
- Completion date
- April 30, 2019
- Enrollment
- 172 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
icu patients